PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1567227
PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1567227
Bacteriostatic Water for Injection Market, By Container Type, By Application, By End User, By Geography
Global bacteriostatic water for injection market is estimated to be valued at USD 1.22 Billion in 2024 and is expected to reach USD 2.09 Billion by 2031, exhibiting a compound annual growth rate (CAGR) of 8% from 2024 to 2031.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2023 | Market Size in 2024: | US$ 1.22 Bn |
| Historical Data for: | 2019 to 2023 | Forecast Period: | 2024 to 2031 |
| Forecast Period 2024 to 2031 CAGR: | 8.00% | 2031 Value Projection: | US$ 2.09 Bn |
Bacteriostatic water for injection refers to sterile water that contains a suitable concentration of preservative to inhibit the growth of micro-organisms inoculated during its preparation or intended use. Bacteriostatic water is used in the reconstitution of powdered medications and other preparations to eliminate the risk of microbial contamination during injection or infusion. It is used in hospitals and clinics for reconstituting medications such as antibiotics, antifungal drugs and other injectable drugs. Growing prevalence of chronic and infectious diseases worldwide along with rising healthcare expenditures can boost demand for bacteriostatic water for injection over the forecast period.
Market Dynamics:
Increasing prevalence of chronic diseases such as cancer and cardiovascular disorders can boost demand for various therapeutic injectable drugs, and this is expected to drive the global bacteriostatic water for injection market growth during the forecast period. Rising healthcare expenditures along with improving access to healthcare facilities especially in developing countries can drive the market growth. However, availability of substitute products such as normal saline can hamper the market growth. Meanwhile, ongoing research towards development of more effective preservatives and formulations compatible with wider range of injectable drugs can offer lucrative opportunities for manufacturers in the near future.
Key features of the study:
This report provides in-depth analysis of the global bacteriostatic water for injection market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
Key companies covered as a part of this study include B. Braun Medical Inc, HOSPIRA, Medline, Baxter, ICU Medical and Hyperdrug
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global bacteriostatic water for injection market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global bacteriostatic water for injection market
Detailed Segmentation-
- Container Type Insights (Revenue, USD Bn, 2019 - 2031)
- Single-Dose Vials
- Multi-Dose Vials
- Application Insights (Revenue, USD Bn, 2019 - 2031)
- Pharmaceutical Manufacturing
- Medical Use
- Diagnostic Applications
- Others
- End User Insights (Revenue, USD Bn, 2019 - 2031)
- Hospital & Clinics
- Diagnostic Labs
- Research Labs
- Others
- Regional Insights (Revenue, USD Bn 2019 - 2031)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Baxter International Inc.
- Fresenius Kabi AG
- Hospira, Inc.
- Braun Melsungen AG
- Eagle Pharmaceuticals, Inc.
- Sagent Pharmaceuticals, Inc.
- Baxter Healthcare Corporation
- MediPharma
- AstraZeneca
- Hikma Pharmaceuticals PLC
- Amgen Inc.
- Teva Pharmaceutical Industries Ltd.
- Sandoz (a Novartis division)
- Merck & Co., Inc.
- GlaxoSmithKline PLC
- Cipla Limited
- Sun Pharmaceutical Industries Ltd.
- Roche Holding AG
- Alvogen
- Zydus Cadila
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Container Type
- Market Snapshot, By Application
- Market Snapshot, By End User
- Market Snapshot, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Opportunities
- Impact Analysis
- Market Trends
- Key Developments
- Regulatory Scenario
- Acquisitions and Partnerships Scenario
- Funding and Investments
- PEST Analysis
- Porter's Analysis
4. Global Bacteriostatic Water for Injection Market - Impact of Coronavirus (COVID-19) Pandemic
- Overall Impact
- Government Initiatives
- COVID-19 Impact on the Market
5. Global Bacteriostatic Water for Injection Market, By Container Type, 2019 - 2031, (USD Bn)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Single-Dose Vials
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Multi-Dose Vials
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
6. Global Bacteriostatic Water for Injection Market, By Application, 2019 - 2031, (USD Bn)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Pharmaceutical Manufacturing
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Medical Use
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Diagnostic Applications
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
7. Global Bacteriostatic Water for Injection Market, By End User, 2019 - 2031, (USD Bn)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Hospital & Clinics
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Diagnostic Labs
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Research Labs
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
8. Global Bacteriostatic Water for Injection Market, By Region, 2019 - 2031, (USD Bn)
- Introduction
- Market Share Analysis, By Region, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, For Region, 2020-2031
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Container Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Container Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Container Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Container Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Container Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Container Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 - 2031, (USD Bn)
- North Africa
- Central Africa
- South Africa
9. Competitive Landscape
- Company Profiles
- Baxter International Inc.
- Company Highlights
- Method Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Fresenius Kabi AG
- Company Highlights
- Method Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Hospira, Inc.
- Company Highlights
- Method Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- B. Braun Melsungen AG
- Company Highlights
- Method Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Eagle Pharmaceuticals, Inc.
- Company Highlights
- Method Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Sagent Pharmaceuticals, Inc.
- Company Highlights
- Method Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Baxter Healthcare Corporation
- MediPharma
- AstraZeneca
- Hikma Pharmaceuticals PLC
- Amgen Inc.
- Teva Pharmaceutical Industries Ltd.
- Sandoz (a Novartis division)
- Merck & Co., Inc.
- GlaxoSmithKline PLC
- Cipla Limited
- Sun Pharmaceutical Industries Ltd.
- Roche Holding AG
- Alvogen
- Zydus Cadila
- Baxter International Inc.
10. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
11. References and Research Methodology
- References
- Research Methodology
- About us and Sales Contact
